Patrick Industries
PATK Nasdaq Automotive Parts & Equipment Financials FY2016βFY2025
Patrick Industries' revenue rose 6.3% to $4.0 billion in fiscal 2025. Its operating margin was 7.0%, about the same as 6.9% a year earlier. Free cash flow was $246 million, down 1.9%. It paid out $87 million in dividends and buybacks, 35% of free cash flow. The diluted share count rose 2.8%.
About these figures. Share counts and per-share figures for earlier years are restated for a stock split (1.5-for-1), so every year is on today's share basis.
What Patrick Industries does
No business description yet.
- Legal name
- PATRICK INDUSTRIES INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000076605-26-000013
0000076605
Revenue and margins
Patrick Industries had $4.0B of revenue in fiscal 2025, up 6.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 10.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $246M in fiscal 2025, 6.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Patrick Industries returned $87.2M to shareholders in fiscal 2025, 35% of free cash flow. The diluted share count rose 2.8%.
Value Patrick Industries yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.3B and divides by 34.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.4x Β· peers 10.9x Β· sector 17.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably Patrick Industries can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $123M | $22.8M | $11.4M | $33.6M | $26.4M |
| Debt incl. finance leases | $1.4B | $1.3B | $1.0B | $1.3B | $1.3B |
| Net debt / EBITDA | 2.7x | 2.0x | 2.5x | 3.1x | 2.9x |
| Debt / equity | 1.8x | 1.4x | 1.0x | 1.2x | 1.1x |
| Interest coverage | 7.8x | 8.7x | 3.9x | 3.4x | 3.9x |
| Current ratio | 2.3x | 2.5x | 2.4x | 2.3x | 2.5x |
| Quick ratio | 0.8x | 0.7x | 0.7x | 0.8x | 0.8x |
| Total assets | $2.7B | $2.8B | $2.6B | $3.0B | $3.1B |
| Total liabilities | $1.9B | $1.8B | $1.5B | $1.9B | $1.9B |
| Shareholders' equity | $768M | $955M | $1.0B | $1.1B | $1.2B |
| Net debt (β = net cash) | $1.2B | $1.3B | $1.0B | $1.3B | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$3.7M
6 insiders
Sold, 12 months
$1.5M
1 insider
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Welch M ScottDirector | Bought | 100 | $83.85 | $0.0M | Form 4 |
| May 19, 2026 | Welch M ScottDirector | Bought | 100 | $89.44 | $0.0M | Form 4 |
| May 6, 2026 | Jacob R PetkovichPresident - Marine | Bought | 1,300 | $95.57 | $0.1M | Form 4 |
| May 5, 2026 | Andy L NemethChief Executive Officer, Director | Bought | 10,000 | $88.00 | $0.9M | Form 4 |
| May 5, 2026 | Blake AugsburgerDirector | Bought | 400 | $85.19 | $0.0M | Form 4 |
| May 5, 2026 | Charles R RoederPresident - RV | Bought | 5,750 | $87.83 | $0.5M | Form 4 |
| May 5, 2026 | Matthew S FilerEVP Finance, CFO & Treasurer | Bought | 1,000 | $85.50 | $0.1M | Form 4 |
| May 5, 2026 | Welch M ScottDirector | Bought | 10,050 | $88.23 | $0.9M | Form 4 |
| Mar 12, 2026 | Hugo E GonzalezPres Powersports & Housing/COO | Sold | 13,514 | $113.10 | $1.5M | Form 4 |
| Mar 12, 2026 | Welch M ScottDirector | Bought | 10,000 | $113.68 | $1.1M | Form 4 |
| Mar 6, 2026 | Welch M ScottDirector | Bought | 50 | $116.40 | $0.0M | Form 4 |
| Feb 27, 2026 | Welch M ScottDirector | Bought | 60 | $122.75 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β9.9% | β6.8% | β6.4% |
| Altman Z'' | 3.57 | 3.22 | 3.41 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Patrick Industries PATK | $2.3B | 6.3% | 7.0% | 6.2% | 8.6% | 16.4x | 6 | |
| LCI Industries LCII | $2.1B | 10.2% | 6.8% | 6.8% | 10.2% | 9.9x | 8 | Compare β |
| Visteon VC | $2.0B | β2.5% | β | β | 19.3% | 13.2x | 7 | Compare β |
| Dauch DCH | $1.1B | β4.7% | 1.9% | 2.7% | 1.7% | β | 4 | Compare β |
| Gentex GNTX | $4.3B | 9.6% | 18.7% | 18.1% | 17.4% | 10.9x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.2B | $1.6B | $2.3B | $2.3B | $2.5B | $4.1B | $4.9B | $3.5B | $3.7B | $4.0B |
| Gross profit | $203M | $279M | $416M | $423M | $459M | $801M | $1.1B | $782M | $836M | $913M |
| Operating income | $90.8M | $122M | $178M | $154M | $173M | $352M | $496M | $260M | $258M | $276M |
| Interest expense | $7.1M | $8.6M | $18.4M | $22.1M | $36.1M | $45.0M | $56.9M | $66.3M | $75.9M | $71.4M |
| Pretax income | $83.7M | $113M | $152M | $118M | $130M | $294M | $435M | $191M | $179M | $177M |
| Income tax | $28.1M | $27.4M | $32.1M | $28.3M | $33.3M | $68.9M | $107M | $48.4M | $40.2M | $42.0M |
| Net income | $55.6M | $85.7M | $120M | $89.6M | $97.1M | $225M | $328M | $143M | $138M | $135M |
| Diluted EPS | $1.62 | $2.32 | $3.29 | $2.57 | $2.80 | $6.42 | $8.99 | $4.33 | $4.11 | $3.90 |
| Diluted shares | 0.03B | 0.04B | 0.04B | 0.03B | 0.03B | 0.04B | 0.04B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $97.1M | $99.9M | $200M | $192M | $160M | $252M | $412M | $409M | $327M | $329M |
| Capital expenditure | $15.4M | $22.5M | $34.5M | $27.7M | $32.1M | $64.8M | $79.9M | $59.0M | $75.7M | $82.9M |
| Free cash flow | $81.7M | $77.4M | $166M | $165M | $128M | $187M | $332M | $350M | $251M | $246M |
| Depreciation and amortization | $24.4M | $33.5M | $55.1M | $62.8M | $73.3M | $105M | $131M | $145M | $167M | $170M |
| Stock-based compensation | $6.5M | $10.4M | $14.0M | $15.4M | $16.0M | $22.9M | $21.8M | $19.4M | $16.8M | $19.1M |
| Acquisitions | $139M | $252M | $343M | $56.0M | $306M | $508M | $249M | $25.9M | $412M | $122M |
| Share buybacks | $5.2M | $0.0M | $108M | $3.8M | $23.1M | $48.9M | $77.1M | $18.8M | $4.7M | $32.0M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $5.8M | $23.6M | $27.0M | $32.9M | $42.1M | $50.2M | $55.3M |
| Dividends and buybacks | $5.2M | $0.0M | $108M | $9.6M | $46.7M | $76.0M | $110M | $61.0M | $54.9M | $87.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $6.4M | $2.8M | $6.9M | $139M | $44.8M | $123M | $22.8M | $11.4M | $33.6M | $26.4M |
| Total debt | $273M | $354M | $661M | $705M | $840M | $1.4B | $1.3B | $1.0B | $1.3B | $1.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $2.0M |
| Current assets | $173M | $274M | $385M | $517M | $528M | $974M | $910M | $735M | $823M | $873M |
| Current liabilities | $86.1M | $136M | $158M | $187M | $227M | $433M | $367M | $309M | $354M | $349M |
| Inventory | $120M | $175M | $273M | $254M | $313M | $614M | $668M | $510M | $552M | $595M |
| Property and equipment, net | $85.5M | $119M | $177M | $181M | $252M | $320M | $351M | $354M | $385M | $409M |
| Total assets | $535M | $867M | $1.2B | $1.5B | $1.8B | $2.7B | $2.8B | $2.6B | $3.0B | $3.1B |
| Total liabilities | $350M | $496M | $823M | $974M | $1.2B | $1.9B | $1.8B | $1.5B | $1.9B | $1.9B |
| Shareholders' equity | $185M | $371M | $409M | $498M | $559M | $768M | $955M | $1.0B | $1.1B | $1.2B |
| Margins | ||||||||||
| Gross margin | 16.6% | 17.1% | 18.4% | 18.1% | 18.5% | 19.7% | 21.7% | 22.6% | 22.5% | 23.1% |
| Operating margin | 7.4% | 7.5% | 7.9% | 6.6% | 7.0% | 8.6% | 10.2% | 7.5% | 6.9% | 7.0% |
| EBITDA margin | 9.4% | 9.5% | 10.3% | 9.3% | 9.9% | 11.2% | 12.8% | 11.7% | 11.4% | 11.3% |
| Net margin | 4.6% | 5.2% | 5.3% | 3.8% | 3.9% | 5.5% | 6.7% | 4.1% | 3.7% | 3.4% |
| FCF margin | 6.7% | 4.7% | 7.3% | 7.1% | 5.2% | 4.6% | 6.8% | 10.1% | 6.8% | 6.2% |
| Returns | ||||||||||
| Return on capital | 15.4% | 15.8% | 15.8% | 11.0% | 10.7% | 16.0% | 17.7% | 9.0% | 8.9% | 8.6% |
| Return on capital employed | 23.5% | 20.7% | 19.8% | 13.1% | 12.3% | 18.8% | 21.4% | 11.2% | 10.5% | 10.2% |
| Return on equity | 35.4% | 30.8% | 30.8% | 19.8% | 18.4% | 33.9% | 38.1% | 14.3% | 12.7% | 11.7% |
| Return on assets | 12.1% | 12.2% | 11.4% | 6.6% | 6.0% | 10.2% | 12.1% | 5.4% | 5.0% | 4.4% |
| Growth | ||||||||||
| Revenue growth | 32.8% | 33.9% | 38.4% | 3.3% | 6.4% | 64.0% | 19.7% | β29.0% | 7.1% | 6.3% |
| Net income growth | 31.6% | 54.2% | 39.8% | β25.3% | 8.4% | 131.7% | 45.9% | β56.5% | β3.2% | β2.4% |
| EPS growth | 34.3% | 43.2% | 41.7% | β21.9% | 9.1% | 129.3% | 40.0% | β51.8% | β5.1% | β5.1% |
| FCF growth | 38.8% | β5.3% | 113.9% | β0.5% | β22.3% | 46.3% | 77.2% | 5.4% | β28.2% | β1.9% |
| Share count change | β1.5% | 7.6% | β1.3% | β4.3% | β0.8% | 1.2% | 4.8% | β10.0% | 2.0% | 2.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.3x | 2.3x | 2.8x | 2.6x | 3.2x | 2.7x | 2.0x | 2.5x | 3.1x | 2.9x |
| Debt / equity | 1.5x | 1.0x | 1.6x | 1.4x | 1.5x | 1.8x | 1.4x | 1.0x | 1.2x | 1.1x |
| Interest coverage | 12.8x | 14.2x | 9.7x | 7.0x | 4.8x | 7.8x | 8.7x | 3.9x | 3.4x | 3.9x |
| Current ratio | 2.0x | 2.0x | 2.4x | 2.8x | 2.3x | 2.3x | 2.5x | 2.4x | 2.3x | 2.5x |
| Quick ratio | 0.6x | 0.7x | 0.7x | 1.4x | 1.0x | 0.8x | 0.7x | 0.7x | 0.8x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.3% | 1.4% | 1.5% | 1.2% | 1.3% | 1.6% | 1.6% | 1.7% | 2.0% | 2.1% |
| Stock comp / revenue | 0.5% | 0.6% | 0.6% | 0.7% | 0.6% | 0.6% | 0.5% | 0.6% | 0.5% | 0.5% |
| Payouts / FCF | 6.4% | 0.0% | 65.0% | 5.8% | 36.5% | 40.6% | 33.1% | 17.4% | 21.8% | 35.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 5.0 | 6.0 |
| Altman Z'' | 3.5 | 3.5 | 3.3 | 3.4 | 3.0 | 3.3 | 3.9 | 3.6 | 3.2 | 3.4 |
| Accruals ratio | β9.1% | β2.0% | β7.6% | β7.6% | β3.9% | β1.2% | β3.1% | β9.9% | β6.8% | β6.4% |
Source: SEC EDGAR XBRL filings (CIK 0000076605). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.